Efficacy of Flunarizine Vs Amitriptyline in Prophylaxis of Migraine Prophylaxis

NCT06162819 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2023-12-29

No results posted yet for this study

Summary

To compare the frequency of acute attack and mean pain score ( assessed by visual analog scale) among subjects using either flunarizine or amitriptyline among patients with migraine coming to tertiary care Hospital in Lahore, Pakistan.

In this study 84 patients with migraine Age ranged between 18- 60 years, Both genders having 3 or more migraine attacks per month, normal systemic and neurological examination and not having taken any prophylactic medication for the last 4 months will randomly divided into two equal group of 42 subjects each.

Conditions

Interventions

DRUG

Amitriptyline

Amitriptyline will be used for prophylaxis of migraine, also used as antidepressant

DRUG

Flunarizine 5mg

Flunarizine will be used for prophylaxis of migraine,

Sponsors & Collaborators

  • Shalamar Institute of Health Sciences

    lead OTHER

Principal Investigators

  • Mujeeb-ur-Rehman Abid Butt, FCPS · Shalamar Institute of Health Sciences

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2024-06-30
Completion
2024-09-30

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06162819 on ClinicalTrials.gov